Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gliomatosis peritonei.

S N Nielsen, B W Scheithauer, T A Gaffey

    Cancer
    |November 15, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Gliomatosis peritonei, a rare complication of ovarian teratoma, involves glial implants in the abdomen. While generally benign, its prognostic significance requires careful histopathologic evaluation of peritoneal implants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expression of leukemia inhibitory factor in craniopharyngioma.

    Endocrine pathology·2016
    Same author

    Localization of vascular endothelial growth factor in nontumorous human pituitaries.

    Endocrine pathology·2016
    Same author

    Invasive thymoma metastatic to the cavernous sinus.

    Surgical neurology international·2013
    Same author

    A 10-year follow up of reproductive function in women treated for childhood cancer.

    Reproductive biomedicine online·2013
    Same author

    Tumefactive demyelination and glioblastoma: a rare collision lesion.

    Clinical neuropathology·2011
    Same author

    Dysembryoplastic neuroepithelial tumor and calcifying pseudoneoplasms of the neuraxis: a collision of two seizure-associated lesions.

    Clinical neuropathology·2011
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Gynecologic Oncology
    • Pathology
    • Reproductive Medicine

    Background:

    • Gliomatosis peritonei is a rare condition characterized by mature glial implants within the peritoneum.
    • It is almost exclusively associated with ovarian teratoma, a germ cell tumor.

    Observation:

    • This study describes the clinicopathologic features of four cases of gliomatosis peritonei linked to ovarian teratomas of varying grades.
    • The cases highlight the occurrence of this rare complication in conjunction with ovarian teratoma.

    Findings:

    • Gliomatosis peritonei is considered a benign condition.
    • Contrary to some beliefs, the presence of gliomatosis peritonei did not consistently indicate a more favorable prognosis in high-grade ovarian teratoma cases within this series.
    • Extensive histopathologic sampling of peritoneal implants is crucial.

    Related Experiment Videos

    Implications:

    • Thorough examination of peritoneal implants is essential to rule out adverse prognostic factors such as other teratomatous or germ cell elements.
    • Accurate diagnosis and staging are critical for managing patients with ovarian teratoma and associated gliomatosis peritonei.